RecruitingNCT05437965

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis


Sponsor

China National Center for Cardiovascular Diseases

Enrollment

1,000 participants

Start Date

Jun 3, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years;
  • Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
  • Patients fully informed about the trial procedures who provide written informed consent.

Exclusion Criteria10

  • Patients presenting with any of the following:
  • Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;
  • Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
  • Variant angina (Prinzmetal's angina);
  • Coronary artery dissection;
  • Thrombophilia;
  • Stent underexpansion.
  • Presence of psychiatric disorders;
  • Known inability to complete expected study follow-up for any reason;
  • Patients deemed ineligible for enrollment by the investigator.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTreatment made by experienced clinicians

Treatment made by experienced clinicians


Locations(1)

Jia Lei

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05437965


Related Trials